Apogee Therapeutics APGE 深 沪
等待开盘 08-19 09:30:00 美东时间
134.57
-0.020
-0.01%
华盛通- 最 高134.60
- 今 开134.55
- 成交量 99.22万股
- 最 低 134.54
- 昨 收 134.59
- 总市值 101.85亿
- 52周最高 134.88
- 市盈率 静 --
- 换手率 1.31%
- 52周最低 35.39
- 委 比 -96.76%
- 总股本 7568.77万
- 历史最高 134.88
- 量 比 0.76
- 振 幅 0.04%
- 历史最低 14.19
- 每 手 1
- 风险率 28.65%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Corcept, Revolution Medicines lead ten large-cap healthcare stocks surging in 2026
As the Q2 earnings season draws to a close, investors are turning their attention to broader metrics to identify sustainable market leaders. With corporate report cards nearly finalized, assessing yea...
08-17 20:26
华盛早报 | 伯克希尔、段永平、李录、索罗斯等Q2持仓曝光！美政府抵制苹果采用中国芯片；英伟达缩减OpenAI数据中心担保规模逾5成
伯克希尔、段永平、李录、索罗斯等Q2持仓曝光！特朗普政府施压苹果：禁用中国存储芯片；降幅超5成！英伟达缩减对OpenAI数据中心担保规模>>
08-17 08:19
美股大行评级 | 潜在涨幅544.53%！Scynexis获古根海姆升目标价至33美元，维持"买入"评级
今日重点评级关注：古根海姆：维持Scynexis"买入"评级，目标价从24美元升至33美元；韦德布什：维持Kura Oncology"跑赢大市"评级，目标价从36美元升至38美元
08-14 11:51
Truist Securities Maintains Hold on Apogee Therapeutics, Raises Price Target to $135
Truist Securities analyst Danielle Brill maintains Apogee Therapeutics (NASDAQ:APGE) with a Hold and raises the price target from $81 to $135.
08-13 23:46
BTIG Downgrades Apogee Therapeutics to Neutral
BTIG analyst Julian Harrison downgrades Apogee Therapeutics (NASDAQ:APGE) from Buy to Neutral.
08-12 18:29
Apogee Shareholders Approve AbbVie Acquisition and Leadership Transition
Apogee Therapeutics ( ($APGE) ) has provided an update. On August 11, 2026, Apo...
08-12 04:40
High-flyer healthcare stocks: Ten names with strong momentum, weak valuations
Wall Street investors are increasingly seeking refuge in high-performing equity plays as volatile healthcare markets continue to shift, forcing a critical evaluation of stock price velocity against fu...
08-10 20:49
财报速睇 | Apogee Therapeutics 2026财年Q2营收0.00亿美元，同比增长0.0%；归母净利润亏损0.86亿美元，同比亏损扩大29.9%
华盛资讯8月10日讯，Apogee Therapeutics公布2026财年Q2业绩，公司Q2营收0.00亿美元，同比增长0.0%，归母净利润亏损0.86亿美元，同比亏损扩大29.9%。
08-10 20:02
财报速睇 | Apogee Therapeutics 2026财年Q2营收0.00亿美元，同比增长0.0%；归母净利润亏损0.86亿美元，同比亏损扩大29.9%
华盛资讯8月10日讯，Apogee Therapeutics公布2026财年Q2业绩，公司Q2营收0.00亿美元，同比增长0.0%，归母净利润亏损0.86亿美元，同比亏损扩大29.9%。
08-10 19:31
Apogee Therapeutics Q2 EPS $(1.14) Misses $(1.05) Estimate
Apogee Therapeutics (NASDAQ:APGE) reported quarterly losses of $(1.14) per share which missed the analyst consensus estimate of $(1.05) by 8.57 percent. This is a 0.88 percent decrease over losses of $(1.13) per share from the same period last year.
08-10 19:22
